ALT
Price
$6.87
Change
-$0.05 (-0.72%)
Updated
Jun 16, 04:59 PM (EDT)
Capitalization
561.26M
52 days until earnings call
RCKT
Price
$2.88
Change
-$0.05 (-1.71%)
Updated
Jun 16, 04:59 PM (EDT)
Capitalization
315.67M
56 days until earnings call
Interact to see
Advertisement

ALT vs RCKT

Header iconALT vs RCKT Comparison
Open Charts ALT vs RCKTBanner chart's image
Altimmune
Price$6.87
Change-$0.05 (-0.72%)
Volume$44.88K
Capitalization561.26M
Rocket Pharmaceuticals
Price$2.88
Change-$0.05 (-1.71%)
Volume$40.97K
Capitalization315.67M
ALT vs RCKT Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. RCKT commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Hold and RCKT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (ALT: $6.92 vs. RCKT: $2.93)
Brand notoriety: ALT and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 166% vs. RCKT: 58%
Market capitalization -- ALT: $561.26M vs. RCKT: $315.67M
ALT [@Biotechnology] is valued at $561.26M. RCKT’s [@Biotechnology] market capitalization is $315.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $356.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALT and RCKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 4 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • ALT’s TA Score: 4 bullish, 4 bearish.
  • RCKT’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RCKT is a better buy in the short-term than ALT.

Price Growth

ALT (@Biotechnology) experienced а +23.13% price change this week, while RCKT (@Biotechnology) price change was -4.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.01%. For the same industry, the average monthly price growth was +10.36%, and the average quarterly price growth was +8.87%.

Reported Earning Dates

ALT is expected to report earnings on Aug 07, 2025.

RCKT is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-2.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALT($561M) has a higher market cap than RCKT($316M). ALT YTD gains are higher at: -4.022 vs. RCKT (-76.691). ALT has higher annual earnings (EBITDA): -90.75M vs. RCKT (-246.03M). RCKT has more cash in the bank: 318M vs. ALT (150M). ALT has less debt than RCKT: ALT (1.59M) vs RCKT (25.4M). ALT has higher revenues than RCKT: ALT (20K) vs RCKT (0).
ALTRCKTALT / RCKT
Capitalization561M316M178%
EBITDA-90.75M-246.03M37%
Gain YTD-4.022-76.6915%
P/E RatioN/AN/A-
Revenue20K0-
Total Cash150M318M47%
Total Debt1.59M25.4M6%
FUNDAMENTALS RATINGS
ALT vs RCKT: Fundamental Ratings
ALT
RCKT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
15
Undervalued
PROFIT vs RISK RATING
1..100
89100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
4598
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (15) in the Biotechnology industry is significantly better than the same rating for ALT (98) in the Miscellaneous Commercial Services industry. This means that RCKT’s stock grew significantly faster than ALT’s over the last 12 months.

ALT's Profit vs Risk Rating (89) in the Miscellaneous Commercial Services industry is in the same range as RCKT (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to RCKT’s over the last 12 months.

ALT's SMR Rating (97) in the Miscellaneous Commercial Services industry is in the same range as RCKT (97) in the Biotechnology industry. This means that ALT’s stock grew similarly to RCKT’s over the last 12 months.

ALT's Price Growth Rating (45) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for RCKT (98) in the Biotechnology industry. This means that ALT’s stock grew somewhat faster than RCKT’s over the last 12 months.

ALT's P/E Growth Rating (100) in the Miscellaneous Commercial Services industry is in the same range as RCKT (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTRCKT
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 20 days ago
89%
Bearish Trend 21 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIJDX40.130.70
+1.78%
Fidelity Advisor Gold Z
HGHSX37.23-0.21
-0.56%
Hartford Healthcare R4
WFPRX47.51-0.58
-1.21%
Allspring Special Mid Cap Value R6
AFOZX17.82-0.22
-1.22%
Alger Mid Cap Focus Z
IICAX11.23-0.15
-1.32%
AMF Large Cap Equity AMF

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with CRNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
-3.22%
CRNX - ALT
50%
Loosely correlated
-1.24%
COGT - ALT
47%
Loosely correlated
-1.94%
VKTX - ALT
46%
Loosely correlated
-8.75%
XNCR - ALT
46%
Loosely correlated
-2.55%
CLDX - ALT
45%
Loosely correlated
+4.47%
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with SVRA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
-4.56%
SVRA - RCKT
61%
Loosely correlated
-2.21%
PRTA - RCKT
55%
Loosely correlated
+0.20%
CCCC - RCKT
49%
Loosely correlated
+3.70%
XERS - RCKT
45%
Loosely correlated
-1.58%
ALT - RCKT
44%
Loosely correlated
-3.22%
More